AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells

Oncol Rep. 2008 Dec;20(6):1553-9.

Abstract

AMP-activated protein kinase (AMPK), an evolutionarily conserved serine/threonine protein kinase, serves as an energy sensor in all eukaryotic cells. Recent findings suggest that AMPK activation strongly suppresses cell proliferation and induces cell apoptosis in a variety of cancer cells. Our study demonstrated that chemopreventive agent curcumin strongly activates AMPK in a p38-dependent manner in CaOV3 ovarian cancer cells. Pretreatment of cells with compound C (AMPK inhibitor) and SB203580 (p38 inhibitor) attenuates curcumin-induced cell death. We also observed that curcumin induces p53 phosphorylation (Ser 15) and both compound C and SB203580 pretreatment inhibit p53 phosphorylation. Collectively, our data suggest that AMPK is a new molecular target of curcumin and AMPK activation partially contributes to the cytotoxic effect of curcumin in ovarian cancer cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Antineoplastic Agents / pharmacology
  • Cell Death
  • Cell Line, Tumor
  • Cell Survival
  • Curcumin / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Expression Regulation, Enzymologic*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / enzymology*
  • Phosphorylation
  • Tetrazolium Salts / pharmacology
  • Thiazoles / pharmacology
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Tetrazolium Salts
  • Thiazoles
  • p38 Mitogen-Activated Protein Kinases
  • AMP-Activated Protein Kinases
  • thiazolyl blue
  • Curcumin